| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | Nurix Therapeutics, Inc. | 2,391,866 | 4.9% | EDGAR |
| SC 13G/A | 2024-02-14 | BAKER BROS. ADVISORS LP | Nurix Therapeutics, Inc. | 4,952,452 | 10.0% | EDGAR |
| SC 13G/A | 2024-02-14 | Redmile Group, LLC | Nurix Therapeutics, Inc. | 5,021,886 | 9.9% | EDGAR |
| SC 13G/A | 2024-02-14 | Deep Track Capital, LP | Nurix Therapeutics, Inc. | 2,997,830 | 6.2% | EDGAR |
| SC 13G | 2024-02-14 | SANDS ARTHUR T | Nurix Therapeutics, Inc. | 2,707,896 | 5.4% | EDGAR |
| SC 13G | 2024-02-13 | VANGUARD GROUP INC | Nurix Therapeutics, Inc. | 2,598,097 | 5.4% | EDGAR |
| SC 13G/A | 2024-02-09 | WASATCH ADVISORS LP | Nurix Therapeutics, Inc. | - | - | EDGAR |
| SC 13G | 2024-02-09 | MORGAN STANLEY | Nurix Therapeutics, Inc. | 3,099,198 | 6.4% | EDGAR |
| SC 13G | 2024-01-29 | ARK Investment Management LLC | Nurix Therapeutics, Inc. | 3,194,999 | 6.6% | EDGAR |
| SC 13G/A | 2024-01-24 | BlackRock Inc. | Nurix Therapeutics, Inc. | 4,643,736 | 9.6% | EDGAR |
| SC 13G/A | 2024-01-23 | STATE STREET CORP | Nurix Therapeutics, Inc. | - | 1.9% | EDGAR |
| SC 13G | 2023-02-24 | Deep Track Capital, LP | Nurix Therapeutics, Inc. | 2,717,171 | 5.8% | EDGAR |
| SC 13G/A | 2023-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | Nurix Therapeutics, Inc. | 3,253,736 | 6.9% | EDGAR |
| SC 13G/A | 2023-02-14 | BAKER BROS. ADVISORS LP | Nurix Therapeutics, Inc. | 4,801,954 | 10.0% | EDGAR |
| SC 13G/A | 2023-02-14 | Redmile Group, LLC | Nurix Therapeutics, Inc. | 4,899,772 | 9.9% | EDGAR |
| SC 13G/A | 2023-02-14 | Deep Track Capital, LP | Nurix Therapeutics, Inc. | 2,266,569 | 4.8% | EDGAR |
| SC 13G/A | 2023-02-14 | Third Rock Ventures III, L.P. | Nurix Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2023-02-10 | STATE STREET CORP | Nurix Therapeutics, Inc. | - | 5.3% | EDGAR |
| SC 13G | 2023-02-08 | WASATCH ADVISORS INC | Nurix Therapeutics, Inc. | - | - | EDGAR |
| SC 13G/A | 2023-01-25 | BlackRock Inc. | Nurix Therapeutics, Inc. | 4,142,528 | 8.8% | EDGAR |